磷酸化
突触蛋白
共核细胞病
丝氨酸
突触蛋白I
生物
α-突触核蛋白
细胞生物学
突触小泡
神经科学
蛋白质磷酸化
功能(生物学)
生物化学
化学
帕金森病
内科学
医学
小泡
蛋白激酶A
疾病
膜
作者
Leonardo A Parra‐Rivas,Kayalvizhi Madhivanan,Lina Wang,Nicholas P. Boyer,Dube Dheeraj Prakashchand,Brent Aulston,Donald Pizzo,Kristen Branes‐Guerrero,Yong Tang,Utpal Das,David Scott,Padmini Rangamani,Subhojit Roy
标识
DOI:10.1101/2022.12.22.521485
摘要
Phosphorylation of α-synuclein at the Serine-129 site (α-syn Ser129P) is an established pathologic hallmark of synucleinopathies, and also a therapeutic target. In physiologic states, only a small fraction of total α-syn is phosphorylated at this site, and consequently, almost all studies to date have focused on putative pathologic roles of this post-translational modification. We noticed that unlike native (total) α-syn that is widely expressed throughout the brain, the overall pattern of α-syn Ser129P is restricted, suggesting intrinsic regulation and putative physiologic roles. Surprisingly, preventing phosphorylation at the Ser-129 site blocked the ability of α-syn to attenuate activity-dependent synaptic vesicle (SV) recycling – widely thought to reflect its normal function. Exploring mechanisms, we found that neuronal activity augments α-syn Ser-129P, and this phosphorylation is required for α-syn binding to VAMP2 and synapsin – two functional binding-partners that are necessary for α-syn function. AlphaFold2-driven modeling suggests a scenario where Ser129P induces conformational changes in the C-terminus that stabilizes this region and facilitates protein-protein interactions. Our experiments indicate that the pathology-associated Ser129P is an unexpected physiologic trigger of α-syn function, which has broad implications for pathophysiology and drug-development.
科研通智能强力驱动
Strongly Powered by AbleSci AI